Deze website maakt gebruik van cookies. We gebruiken cookies om instellingen te onthouden en je bezoek soepeler te laten verlopen. Daarnaast gebruiken we ook cookies voor de verbetering van de website en het verzamelen en analyseren van statistieken. Lees meer over cookies

Home
Natasha van Eijkelenburg

Natasha van Eijkelenburg

Kinderoncoloog, PhD student

Trial- en Datacentrum
Zwaan groep

Telefoon

E-mail secretariaatsolide@prinsesmaximacentrum.nl

Corrigendum to “Implementation of paediatric precision oncology into clinical practice
- mei 2025
- Karin P.S., Langenberg, et al
- European Journal of Cancer
Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine
- mrt. 2025
- Karin P.S., Langenberg, et al
- European Journal of Cancer
Urinary Catecholamines Predict Relapse during Complete Remission in High-Risk Neuroblastoma
- feb. 2025
- Yvette A.H., Matser, et al
- JCO precision oncology
Locoregional control in high-risk neuroblastoma using highly-conformal image-guided radiotherapy, with reduced margins and a boost dose for residual lesions
- jan. 2025
- Atia, Samim, et al
- Radiotherapy and Oncology
Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in Belgium
- sep. 2024
- , et al
- Blood neoplasia

Bekijk alle publicaties

Natasha van Eijkelenburg

Publicaties

Corrigendum to “Implementation of paediatric precision oncology into clinical practice

Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine

Urinary Catecholamines Predict Relapse during Complete Remission in High-Risk Neuroblastoma

Locoregional control in high-risk neuroblastoma using highly-conformal image-guided radiotherapy, with reduced margins and a boost dose for residual lesions

Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in Belgium